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hen the protein folding capacity of the endo-
plasmic reticulum (ER) is challenged, the un-
folded protein response (UPR) maintains ER
homeostasis by regulating protein synthesis and enhanc-
ing expression of resident ER proteins that facilitate protein
maturation and degradation. Here, we report that en-
forced expression of XBP1(S), the active form of the XBP1
transcription factor generated by UPR-mediated splicing of
W
 
XBP1
 
 mRNA, is sufﬁcient to induce synthesis of phosphati-
dylcholine, the primary phospholipid of the ER membrane.
Cells overexpressing XBP1(S) exhibit elevated levels of
membrane phospholipids, increased surface area and vol-
ume of rough ER, and enhanced activity of the cytidine
diphosphocholine pathway of phosphatidylcholine biosyn-
thesis. These data suggest that XBP1(S) links the mamma-
lian UPR to phospholipid biosynthesis and ER biogenesis.
 
Introduction
 
The ER is a dynamic protein-folding compartment that can be
expanded according to the demands placed upon the exocytic
pathway. This is exemplified by the highly developed ER net-
work present in specialized secretory cells such as insulin-
producing 
 
 
 
 cells of the pancreas and antibody-secreting
plasma cells. Yet, the molecular mechanisms that coordinate
the synthesis of protein and lipid components necessary for
ER biogenesis remain poorly understood.
Homeostasis of the ER is regulated in large part by the
unfolded protein response (UPR), a complex signaling system
emanating from the ER membrane that regulates translation and
transcription in response to increased demands on the protein
folding capacity of the ER (Rutkowski and Kaufman, 2004).
One branch of the UPR is directed by the ER membrane-bound
activating transcription factor 6
 
 
 
 and 6
 
 
 
 (ATF6
 
 
 
/
 
 
 
). Regu-
lated intramembrane proteolysis releases the soluble cytosolic
domains of ATF6
 
 
 
/
 
 
 
 to function as basic leucine zipper tran-
scription factors that up-regulate expression of various ER resi-
dent chaperones and folding enzymes (Haze et al., 1999, 2001).
A second branch of the UPR that induces transcription in-
volves X-box binding protein 1 (XBP1). The ER transmembrane
kinase/endoribonucleases IRE1
 
 
 
 (expressed ubiquitously; Tira-
sophon et al., 1998) and 
 
 
 
 (expressed in gut epithelium; Wang et
al., 1998) initiate a novel UPR-mediated mRNA splicing mecha-
nism that modifies 
 
XBP1
 
 transcripts to encode a potent basic leu-
cine zipper transcription factor, XBP1(S). In contrast, unspliced
 
XBP1
 
 mRNA encodes a basic leucine zipper protein, XBP1(U),
that lacks transactivation activity and is more labile than
XBP1(S) (Yoshida et al., 2001; Calfon et al., 2002). Genes iden-
tified as targets of XBP1(S) encode proteins that function in the
ER (Lee et al., 2003; Yoshida et al., 2003). Thus, like ATF6
 
 
 
/
 
 
 
,
the IRE1-XBP1 pathway appears to enhance the ability of the
ER to properly handle an increased load of client proteins.
The differentiation of B-lymphocytes into antibody-
secreting cells requires 
 
XBP1
 
 and its modulation by UPR-
mediated splicing (Iwakoshi et al., 2003), and pancreatic tis-
sue exhibits robust splicing of 
 
XBP1
 
 mRNA (Iwawaki et al.,
2004). Furthermore, synthesis of phosphatidylcholine (PtdCho),
the predominant phospholipid in mammalian ER membranes
(Lykidis and Jackowski, 2001), elevates in B-cells differentiating
in response to lipopolysaccharide (Rush et al., 1991). PtdCho
biosynthesis also increases in macrophages subjected to free
cholesterol loading (Shiratori et al., 1994), another example of
physiologic UPR activation (Feng et al., 2003). Therefore,
UPR activation correlates with the presence of an elaborate ER
in specialized secretory cells and with induction of phospho-
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lipid biosynthesis, but a molecular mechanism linking the UPR
to ER biogenesis has not been elucidated.
Given the roles of the UPR in maintenance of ER homeo-
stasis, we hypothesized that the UPR might regulate overall ER
abundance. Here, we report that enforced expression of a single
transcription factor, XBP1(S), is sufficient to induce PtdCho
biosynthesis, elevate the level of membrane phospholipids,
and trigger expansion of the ER in fibroblasts. These data sug-
gest that XBP1(S) regulates ER biogenesis, revealing another
means by which cells use the UPR to cope with increased de-
mands on the exocytic pathway.
 
Results and discussion
 
Effect of XBP1(S) on phospholipid 
biosynthesis and ER expansion
 
To determine whether mammalian UPR transcriptional ac-
tivators regulate phospholipid biosynthesis, we transduced
NIH-3T3 fibroblasts with retroviral vectors encoding either
XBP1(U), XBP1(S), or a constitutively active form of ATF6
 
 
 
(ATF6
 
 
 
(373); Yoshida et al., 2000). Flow cytometric assess-
ment of GFP, expressed via the bicistronic mRNA encoded by
the retroviral vectors, revealed 
 
 
 
95% transduction efficiency
for all retroviral constructs tested in NIH-3T3 cells (see online
supplemental material, available at http://www.jcb.org/cgi/
content/full/jcb.200406136/DC1). As expected, ATF6
 
 
 
(373)
induced expression of immunoglobulin heavy chain binding pro-
tein (BiP) and the disulfide-isomerase-like protein ERp72, two
ER resident chaperones. In addition, ATF6
 
 
 
(373) up-regulated
ERdj3 (also known as HEDJ), an ER chaperone cofactor that
has been identified as an XBP1 target (Lee et al., 2003) (Fig.
1 A). The XBP1(U) retroviral vector yielded the 
 
 
 
30-kD
pXBP1(U) and no detectable pXBP1(S), whereas the XBP1(S)
virus exclusively yielded the 
 
 
 
54-kD pXBP1(S). Cells trans-
duced with XBP1(S), but not XBP1(U), exhibited increased
levels of ERdj3 and BiP (Fig. 1 A). These data demonstrate that
Figure 1. Phospholipid synthesis in NIH-3T3 fibroblasts
retrovirally transduced with UPR transcriptional activators.
NIH-3T3 cells were transduced with the indicated pBMN-I-
GFP retroviral vectors. (A) At 48 h after transduction, cells
were harvested and equivalent amounts of cell lysate protein
were resolved by standard SDS-PAGE under reducing condi-
tions. Chemiluminescent immunoblotting was performed. A
nonspecific band just below the position of pXBP1(S) was de-
tected by the anti-XBP1 antibody. Calnexin served as a load-
ing control. (B) Cells were metabolically labeled with
[
3H]choline for 2 h, a labeling interval in which [
3H]choline is
incorporated exclusively into PtdCho. The amount of radiola-
bel present in cellular lipid extracts was normalized as cpm/
10
5 cells and was plotted as the mean   SD (n   3; asterisk
denotes P   0.002 for comparison of XBP1(S) to empty vec-
tor). (C) Cells were harvested and total cellular mass of Ptd-
Cho, PtdEtn, and cholesterol was determined by flame ion-
ization. Superscript a: average of triplicate determinations
from two independent experiments (n   6)   SD. Superscript
b: control NIH-3T3 values set at 100% for comparison. 
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ATF6
 
 
 
(373), XBP1(U), and XBP1(S) all functioned as pre-
dicted upon enforced expression in NIH-3T3 cells.
In contrast to ATF6
 
 
 
(373) and XBP1(U), enforced expres-
sion of XBP1(S) resulted in a large (approximately fourfold) in-
crease in PtdCho synthesis (Fig. 1 B). Furthermore, the total
amount of both PtdCho and phosphatidylethanolamine (PtdEtn),
also a major lipid in intracellular membranes (Lykidis and Jack-
owski, 2001), was increased approximately twofold in XBP1(S)-
transduced cells. However, the mass of cholesterol, most prevalent
in the plasma membrane, was unchanged (Fig. 1 C). Therefore,
XBP1(S) has the capacity to mediate substantial increases in
phospholipids that constitute the membranes of intracellular or-
ganelles like the ER. It is important to note that the yeast UPR
has also been implicated in lipid metabolism (Cox et al., 1997).
Electron microscopy revealed that XBP1(S)-transduced
cells contained an increased number of intracellular mem-
brane–bound structures that were frequently studded with ribo-
somes, indicating their identity as RER (Fig. 2 A). Indeed, the
surface area and volume of RER were significantly increased
in XBP1(S)-transduced cells, 2.5- and 3.4-fold, respectively
(Fig. 2 B). Immunofluorescence microscopy demonstrated that
KDEL-containing proteins were distributed throughout the cy-
toplasm of XBP1(S)-transduced cells (Fig. 2 C), consistent
with an overall increase in the amount of ER. In addition,
XBP1(S) induced a 44% increase in cell size (empty vector
cells, 103.9 
 
 
 
 1.8 
 
 
 
m
 
2
 
; XBP1(S) cells, 149.8 
 
 
 
 2.5 
 
 
 
m
 
2
 
).
Cells overexpressing XBP1(S) exhibited a slower rate of pro-
liferation 24 h after transduction, but their viability was not af-
fected through 48 h. Importantly, while this manuscript was
under review, Shaffer et al. (2004) reported that XBP1(S) can
mediate increased cell size and expansion of intracellular or-
ganelles including the ER, thereby corroborating our findings.
Synthesis of XBP1(S) can also be elicited by ER stress-
inducing agents such as the glycosylation inhibitor tunicamy-
cin. In a series of experiments, we observed a trend toward a
small increase (
 
 
 
20%) in PtdCho biosynthesis within 3 to 4 h
of tunicamycin treatment, but this was not sustained in a statis-
tically significant fashion for longer intervals (unpublished
data). Perhaps gross inhibition of protein folding in the ER and/
or complete UPR activation in cells subjected to pharmaco-
logic agents that poison the ER is not compatible with in-
creased phospholipid biosynthesis.
 
Effect of XBP1(S) on the cytidine 
diphosphocholine pathway of PtdCho 
biosynthesis
 
The predominant pathway for PtdCho biosynthesis in mam-
malian cells is the cytidine diphosphocholine (CDP-choline)
Figure 2. Microscopy analysis of the ER. (A) At 48 h after transduction with the indicated retroviral vectors, thin sections were prepared from NIH-3T3
cells and examined by transmission EM. Representative micrographs of increasing magnification (from top to bottom) are shown with scale bar (1  m) in
top right corner: middle panels, arrow indicates representative ER; bottom panels, arrow indicates membrane-bound ribosomes. N, nucleus. (B) Stereolog-
ical analysis of RER volume (top) and RER surface area (bottom) was performed on electron micrographs and the mean   SEM are plotted (n   4 stereo-
logical sets with 2–16 micrographs per set; *, P   0.01). (C) Immunofluorescence analysis (using anti-KDEL mAb) and confocal microscopy was performed
on NIH-3T3 cells grown on coverslips and transduced with the indicated retroviral vectors for 48 h. 
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or Kennedy pathway (Lykidis and Jackowski, 2001). First,
choline kinase (CK) phosphorylates choline in the presence of
ATP to yield phosphocholine. Second, choline cytidylyltrans-
ferase (CCT) converts phosphocholine to CDP-choline in the
presence of CTP, and this is considered to be the rate-limiting
step in the CDP-choline pathway (Lykidis and Jackowski,
2001). Third, cholinephosphotransferase 1 (CPT1) transfers
the phosphocholine moiety of CDP-choline to DAG, produc-
ing PtdCho. This final step can also be catalyzed by choline/
ethanolaminephosphotransferase (CEPT1), a bifunctional en-
zyme that can synthesize both choline- and ethanolamine-
containing phospholipids. Here, we refer to the activities of
CPT1 (Henneberry et al., 2000) and CEPT1 (Henneberry and
McMaster, 1999) collectively as CPT activity. In XBP1(S)-
transduced cells, CK activity was unchanged (Fig. 3 A), CCT
activity increased 
 
 
 
30% (Fig. 3 B), and CPT activity ele-
vated approximately fivefold (Fig. 3 C). Remarkably similar
to these data, increased PtdCho biosynthesis in lipopolysac-
charide-stimulated splenic B cells was previously shown to
correlate with unchanged CK activity, a small increase in
CCT activity, and an approximately sixfold increase in CPT
activity (Rush et al., 1991). Therefore, it follows that XBP1(S)
might mediate the increased synthesis of phospholipids nec-
essary for ER biogenesis as B cells transition into high-rate
antibody secretion.
There are three isoforms of CCT: 
 
 
 
, 
 
 
 
2, and 
 
 
 
3. CCT
 
 
 
 is
ubiquitously expressed, whereas the 
 
 
 
 isoforms exhibit tissue-
specific expression that is 
 
 
 
10-fold lower compared with
CCT
 
 
 
 (Jackowski et al., 2004). Quantitative real-time RT-PCR
revealed no change in transcript levels for any of the CCT
Figure 3. Enzymatic activities in the CDP-choline pathway of PtdCho
synthesis. The relative activities of CK, CCT, and CPT, which constitute the
CDP-choline pathway of PtdCho biosynthesis (right side of figure), were
determined using lysates or microsomes prepared from NIH-3T3 cells ( ),
or NIH-3T3 cells transduced with XBP1(S) ( ) or empty vector ( ). The
rates of production of phosphocholine (P-Choline), CDP-Choline, and Ptd-
Cho were compared as a function of total protein in each assay. (A) Data
for CK are averaged from triplicate determinations and are representative
of two independent experiments. (B) Data for CCT are averaged from five
determinations obtained in two independent experiments. (C) Data for
CPT are averaged from duplicate determinations and are representative of
three independent experiments.
Figure 4. Expression of enzymes that function in the CDP-choline pathway
of PtdCho synthesis. Total RNA was prepared from NIH-3T3 fibroblasts
harvested at 24 and 48 h after transduction with the indicated retroviral
vectors. (A) The relative levels of expression of the CCT ,  2, and  3 iso-
form cDNAs at the 48-h interval were measured by quantitative real-time
PCR. The amount of target RNA was normalized to the endogenous
GAPDH reference and related to the amount of target CCT  in NIH-3T3,
which was set as the calibrator at 1.0 (superscript a). The mean   SD
(superscript b) of triplicate determinations is shown. (B) Northern blot
analysis using 
32P-labeled cDNA probes specific for CEPT1 and CPT1, the
two genes encoding enzymes possessing CPT activity; ERdj3, a known
XBP1 target as a positive control; and  -actin as a loading control. 
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isoforms in XBP1(S)-transduced cells (Fig. 4 A). Likewise,
Northern blotting revealed no change in the steady-state levels
of 
 
CPT1
 
 and 
 
CEPT1
 
 transcripts (Fig. 4 B). These data suggest
that enforced expression of XBP1(S) leads to post-transcrip-
tional and/or post-translational regulation of the CCT
 
 
 
 and
CPT1/CEPT1 enzymes, thereby augmenting their activities and
increasing synthesis of PtdCho (Fig. 5).
CCT
 
 
 
 is an amphitropic enzyme as it transitions from a
soluble form, largely sequestered in the nucleus, into a more
active form associated with ER membranes (Cornell and
Northwood, 2000). Conversion of CCT
 
 
 
 into the membrane-
associated form correlates with dephosphorylation of serine
residues near its carboxy terminus, and this influences its af-
finity for membranes (Lykidis and Jackowski, 2001). Thus,
there are a number of steps at which an XBP1(S)-regulated
gene product might modulate CCT
 
 
 
 activity. Both CPT1 and
CEPT1 contain an estimated seven membrane-spanning helices
and are predicted to reside in the ER membrane (Henneberry
and McMaster, 1999; Henneberry et al., 2000), but very little is
known concerning control of their respective activities. Perhaps
XBP1(S) regulates expression of an allosteric modulator or a
cofactor that enhances the stability of CPT1 and/or CEPT1.
 
Summary
 
Our data regarding XBP1(S) provide the first example of a
transcription factor being sufficient to induce phospholipid
biosynthesis and ER expansion in mammalian cells. Whether
the expanded ER in XBP1(S)-transduced cells is properly or-
ganized and fully functional is under investigation. We pro-
pose that in a physiologic UPR, the IRE1-XBP1 pathway reg-
ulates synthesis of phospholipids according to cellular needs
for ER membrane components (Fig. 5). Interestingly, inhibi-
tion of PtdCho biosynthesis via a thermosensitive mutation in
the CCT enzyme has been correlated with UPR activation
(van der Sanden et al., 2003), providing further evidence that
the UPR might provide a means to rapidly respond to an in-
creased need for phospholipids. Coordinating induction of
phospholipid biosynthesis with up-regulated expression of ER
resident proteins would allow the mammalian UPR to both
build and equip the ER.
 
Materials and methods
 
Plasmids
 
pBMN-I-GFP (Dr. G. Nolan, Stanford University, Palo Alto, CA) encodes a
bicistronic mRNA with a GFP cassette 3
 
 
 
 of the internal ribosomal entry
site (I). pBMN-hATF6(373)-I-GFP encodes aa 1–373 of human ATF6
 
 
 
(Yoshida et al., 2000). pBMN-hXBP1(U)-I-GFP encodes full-length human
XBP1 not modified by UPR-mediated splicing. pBMN-hXBP1(S)-I-GFP en-
codes full-length human XBP1 generated by UPR-mediated splicing.
 
Cell culture and retroviral transduction
 
NIH-3T3 fibroblasts and Phoenix-Eco cells (Dr. G. Nolan) were main-
tained in DME (Gass et al., 2002). Ecotropic retroviruses were produced
using Phoenix-Eco packaging cells (Gunn et al., 2004) and pBMN plas-
mids. Cells were transduced with retroviruses (Brewer and Diehl, 2000)
with 
 
 
 
95% efficiency, as measured by GFP fluorescence using a FACS-
Calibur flow cytometer (BD Biosciences). Tunicamycin (Sigma-Aldrich) was
used at 0.5 
 
 
 
g/ml.
 
Immunoblotting and Northern blotting
 
Chemiluminescent immunoblotting of BiP, XBP1, and calnexin was per-
formed as described previously (Gass et al., 2002). The ERdj3 antisera
was provided by Dr. Linda Hendershot (St. Jude Children’s Research Hos-
pital, Memphis, TN). Rabbit anti–mouse ERp72 antibody (SPA-720; Stress-
gen Biotechnologies) and mouse anti-
 
 
 
 actin mAb (clone AC-15; Sigma-
Aldrich) were purchased. Northern blotting was performed as described
previously (Gass et al., 2002). Probes used in this work are described in
the online supplemental material.
 
Detection of CCT isoform mRNAs by real-time PCR
 
Quantitative real-time PCR of the 
 
CCT
 
 
 
, 
 
 
 
2
 
, and 
 
 
 
3
 
 isoform cDNAs was
performed as described previously (Karim et al., 2003). For details, see
online supplemental material.
 
Analysis of PtdCho synthesis
 
Cells were cultured for 2 h at 37
 
 
 
C in DME containing 2 
 
 
 
Ci/ml
methyl[
 
3
 
H]choline chloride (81 Ci/mmol; Amersham Biosciences). In tuni-
camycin experiments, labeling was performed during the final 2 h of treat-
ment. After labeling, cells were washed with cold PBS and scraped in
methanol/water (2:0.8, vol/vol). Lipids were extracted as described pre-
viously (Bligh and Dyer, 1959). Radiolabel incorporated into chloro-
form-soluble metabolites was determined by scintillation spectroscopy.
The organic phase was subjected to TLC in chloroform/methanol/water
(65:35:4, vol/vol/vol) to verify that detectable radioactivity was present
exclusively in PtdCho.
Phospholipid mass determinations
Frozen cell pellets (2   10
7 cells) were thawed on ice and resuspended in
1 ml of water. The total volume was measured and a 100- l aliquot was
removed for protein determination. The remainder of the lysate was ex-
tracted as described previously (Bligh and Dyer, 1959). Lipids were de-
tected by flame ionization using an Iatroscan instrument (Iatron Laborato-
Figure 5. A model for how XBP1 links the UPR to ER biogenesis. In re-
sponse to increased demand on the protein folding capacity of the ER,
UPR-mediated splicing of XBP1 mRNA yields the XBP1(S) transcriptional
activator. We propose that XBP1(S) induces expression of unknown gene
products that lead to an increase in CCT activity and a large increase in
CPT activity, thereby augmenting synthesis of PtdCho. Increased produc-
tion of PtdCho, the major phospholipid of the ER membrane, is critical for
expansion of the ER compartment.JCB • VOLUME 167 • NUMBER 1 • 2004 40
ries) with PEAK SIMPLE software (SRI Instruments). Peaks were identified
by comigration with authentic standards. PtdCho, PtdEtn, and cholesterol
mass were calculated using standard curves for each prepared with either
the polar lipid (no. 1127) or the neutral lipid (no. 1129) mixture
(Matreya, Inc.). For details, see online supplemental material.
CK, CCT, and CPT assays
Pelleted frozen cells (2   10
7 cells) were used for assays of CK and CCT
enzymatic activity as described previously (Lykidis et al., 1999, 2001).
CPT activity was assessed as described previously (Henneberry and Mc-
Master, 1999) using microsomes prepared from frozen cell pellets (2  
10
7 cells). The assays were linear through the time of incubation at all pro-
tein concentrations. For details, see online supplemental material.
Immunofluorescence microscopy
NIH-3T3 cells were seeded on glass coverslips in 60-mm dishes. At 48 h af-
ter transduction, cells were fixed on coverslips with 95% ethanol/5% acetic
acid for 10 min at  20 C, blocked with PBS containing 5% FCS at RT, and
then stained with mouse anti-KDEL mAb (SPA-827; StressGen Biotechnolo-
gies) or mouse IgG (Southern Biotechnology Associates) as an isotype con-
trol, followed by biotinylated goat anti–mouse IgG (Southern Biotechnology
Associates) and R-phycoerythrin–conjugated streptavidin (Molecular Probes,
Inc.). Coverslips were mounted in ProLong Antifade (Molecular Probes, Inc.)
and were examined on a confocal microscope (LSM-510; Carl Zeiss Micro-
Imaging, Inc.). Images were assessed using the LSM Browser (Carl Zeiss Mi-
croImaging, Inc.) and were processed using Adobe Photoshop software.
Electron microscopy
Retrovirally transduced NIH-3T3 cells were trypsinized, pelleted by centrif-
ugation, fixed in cacodylate buffer containing 4% glutaraldehyde, and
washed in cacodylate buffer. Cells were then postfixed with 1% osmium
tetroxide prepared in cacodylate buffer, dehydrated by sequential extrac-
tion with graded concentrations of ethanol from 25 to 100%, and embed-
ded in Embed 812 resin. Thin sections were cut on an ultramicrotome
(Reichert), mounted on nickel grids, stained with saturated uranyl ace-
tate and Reynolds lead citrate, and examined at 2,500, 8,000, and
20,000  at RT using a transmission electron microscope (model H-600;
Hitachi). Images were captured on 35-mm film and were processed using
Adobe Photoshop software.
Stereological measurements of RER and cell size determinations
Four independent stereological sets containing electron micrographs of
empty vector– and XBP1(S)-transduced cells at magnifications of 8,000
and 20,000 were analyzed. RER volume was measured by determining the
volume fraction (Vv) with a grid containing test points in the linear array
(1-cm spacing). Vv is equal to the number of test points falling on RER di-
vided by the number of test points falling on the containing space. RER sur-
face area was calculated by determining the surface density (Sv). Sv is equal
to two times the number of line intersections with RER membrane, divided by
the total length of line on the containing space (Weibel and Bolender,
1973). Average cell size was determined from light microscopy analysis of
thick sections using the Scion image program. The mean cell area ( m
2)
was determined in a minimum of 38 fields, and SEM was calculated.
Statistical analysis
Both one-tailed and two-tailed independent t tests were used to compare
test samples to controls. In all cases, both tests were in agreement. P val-
ues in figure legends correspond to results of one-tailed t tests.
Online supplemental material
Fig. S1 shows flow cytometric analysis of GFP expression in NIH-3T3
cells transduced with pBMN-I-GFP retroviral vectors encoding either
ATF6 (373), XBP1(U) or XBP1(S). Details are provided for: detection of
CCT isoform mRNAs by real-time PCR; northern hybridization probes; as-
says for enzymatic activities of CK, CCT, and CPT; phospholipid mass
determinations. Online supplemental material available at http://www.
jcb.org/cgi/content/full/jcb.200406136/DC1.
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